# Group-3-Pulmonary-Hypertension
Pulmonary hypertension (PH) in chronic lung disease is common, linked to poor prognosis and has no long-term data to understand treatment strategies. We present longitudinal cohort (n=184) of incident group 3 PH patients with over 380 patient.years follow up to understand the associations of treatment with survival. All code used in the analysis is given below.

